{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T10:53:29Z","timestamp":1793962409849,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2021,4,1]]},"DOI":"10.1038\/s41388-021-01724-6","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T15:04:25Z","timestamp":1614956665000},"page":"2437-2447","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun"],"prefix":"10.1038","volume":"40","author":[{"given":"Maria","family":"Riedel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Berthelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiqiang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Haldrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Borre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9180-4060","authenticated-orcid":false,"given":"S\u00f8ren R.","family":"Paludan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Hager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel H.","family":"Vendelbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7872-0196","authenticated-orcid":false,"given":"Erwin F.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6300-2420","authenticated-orcid":false,"given":"Latifa","family":"Bakiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5055-7531","authenticated-orcid":false,"given":"Martin K.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,5]]},"reference":[{"key":"1724_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"key":"1724_CR2","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ncpuro1296","volume":"6","author":"WP Harris","year":"2009","unstructured":"Harris WP, Mostaghel EA, Nelson PS, Montgomery B. Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletion. Nat Clin Pract Urol. 2009;6:76\u201385.","journal-title":"Nat Clin Pract Urol"},{"key":"1724_CR3","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1038\/modpathol.2017.158","volume":"31","author":"AJ Evans","year":"2018","unstructured":"Evans AJ. Treatment effects in prostate cancer. Mod Pathol. 2018;31:S110\u201321.","journal-title":"Mod Pathol"},{"key":"1724_CR4","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"The Cancer Genome Atlas Research Network.","year":"2015","unstructured":"The Cancer Genome Atlas Research Network. The molecular taxonomy of primary prostate cancer. Cell. 2015;163:1011\u201325.","journal-title":"Cell"},{"key":"1724_CR5","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1101\/gad.315739.118","volume":"32","author":"G Wang","year":"2018","unstructured":"Wang G, Zhao D, Spring DJ, DePinho RA. Genetics and biology of prostate cancer. Genes Dev. 2018;32:1105\u201340.","journal-title":"Genes Dev"},{"key":"1724_CR6","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1038\/sj.onc.1204383","volume":"20","author":"E Shaulian","year":"2001","unstructured":"Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene. 2001;20:2390\u2013400.","journal-title":"Oncogene"},{"key":"1724_CR7","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1038\/ncb0502-e131","volume":"4","author":"E Shaulian","year":"2002","unstructured":"Shaulian E, Karin M. AP-1 as a regulator of cell life and death. Nat Cell Biol. 2002;4:E131\u20136.","journal-title":"Nat Cell Biol"},{"key":"1724_CR8","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrc1209","volume":"3","author":"R Eferl","year":"2003","unstructured":"Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003;3:859\u201368.","journal-title":"Nat Rev Cancer"},{"key":"1724_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/path.1605","volume":"204","author":"J Edwards","year":"2004","unstructured":"Edwards J, Krishna NS, Mukherjee R, Bartlett JM. The role of c-Jun and c-Fos expression in androgen-independent prostate cancer. J Pathol. 2004;204:153\u20138.","journal-title":"J Pathol"},{"key":"1724_CR10","doi-asserted-by":"publisher","first-page":"4408","DOI":"10.1158\/1078-0432.CCR-07-4120","volume":"14","author":"N Konishi","year":"2008","unstructured":"Konishi N, Shimada K, Nakamura M, Ishida E, Ota I, Tanaka N, et al. Function of JunB in transient amplifying cell senescence and progression of human prostate cancer. Clin Cancer Res. 2008;14:4408\u201316.","journal-title":"Clin Cancer Res"},{"key":"1724_CR11","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/cdd.2014.213","volume":"22","author":"MK Thomsen","year":"2015","unstructured":"Thomsen MK, Bakiri L, Hasenfuss SC, Wu H, Morente M, Wagner EF. Loss of JUNB\/AP-1 promotes invasive prostate cancer. Cell Death Differ. 2015;22:574\u201382.","journal-title":"Cell Death Differ"},{"key":"1724_CR12","doi-asserted-by":"publisher","first-page":"109679","DOI":"10.1016\/j.biopha.2019.109679","volume":"121","author":"R Xu","year":"2020","unstructured":"Xu R, Hu J. The role of JNK in prostate cancer progression and therapeutic strategies. Biomed Pharmacother. 2020;121:109679.","journal-title":"Biomed Pharmacother"},{"key":"1724_CR13","doi-asserted-by":"publisher","first-page":"12046","DOI":"10.1073\/pnas.1209660109","volume":"109","author":"A Hubner","year":"2012","unstructured":"Hubner A, Mulholland DJ, Standen CL, Karasarides M, Cavanagh-Kyros J, Barrett T, et al. JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate. Proc Natl Acad Sci USA. 2012;109:12046\u201351.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1724_CR14","doi-asserted-by":"publisher","first-page":"17964","DOI":"10.1074\/jbc.M116.714899","volume":"291","author":"AC Millena","year":"2016","unstructured":"Millena AC, Vo BT, Khan SA. JunD is required for proliferation of prostate cancer cells and plays a role in transforming growth factor-\u03b2 (TGF-\u03b2)-induced inhibition of cell proliferation. J Biol Chem. 2016;291:17964\u201376.","journal-title":"J Biol Chem"},{"key":"1724_CR15","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1158\/0008-5472.CAN-07-6055","volume":"68","author":"X Ouyang","year":"2008","unstructured":"Ouyang X, Jessen WJ, Al-Ahmadie H, Serio AM, Lin Y, Shih WJ, et al. Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Res. 2008;68:2132\u201344.","journal-title":"Cancer Res"},{"key":"1724_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-5-45","volume":"5","author":"UR Chandran","year":"2005","unstructured":"Chandran UR, Dhir R, Ma C, Michalopoulos G, Becich M, Gilbertson J. Differences in gene expression in prostate cancer, normal appearing prostate tissue adjacent to cancer and prostate tissue from cancer free organ donors. BMC Cancer. 2005;5:45.","journal-title":"BMC Cancer"},{"key":"1724_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.molonc.2013.02.005","volume":"7","author":"M Parisotto","year":"2013","unstructured":"Parisotto M, Metzger D. Genetically engineered mouse models of prostate cancer. Mol Oncol. 2013;7:190\u2013205.","journal-title":"Mol Oncol"},{"key":"1724_CR18","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","volume":"159","author":"RJ Platt","year":"2014","unstructured":"Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, et al. CRISPR-Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014;159:440\u201355.","journal-title":"Cell"},{"key":"1724_CR19","doi-asserted-by":"crossref","unstructured":"Riedel M, Berthelsen MF, Bakiri L, Wagner EF, Thomsen MK. Virus delivery of CRISPR guides to the murine prostate for gene alteration. J Vis Exp. 2018:57525.","DOI":"10.3791\/57525"},{"key":"1724_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-64","volume":"7","author":"UR Chandran","year":"2007","unstructured":"Chandran UR, Ma C, Dhir R, Bisceglia M, Lyons-Weiler M, Liang W, et al. Gene expression profiles of prostate cancer reveal involvement of multiple molecular pathways in the metastatic process. BMC Cancer. 2007;7:64.","journal-title":"BMC Cancer"},{"key":"1724_CR21","doi-asserted-by":"publisher","first-page":"2593","DOI":"10.1038\/sj.onc.1202195","volume":"17","author":"Z Feng","year":"1998","unstructured":"Feng Z, Joos HJ, Vallan C, Muhlbauer R, Altermatt HJ, Jaggi R. Apoptosis during castration-induced regression of the prostate is Fos dependent. Oncogene. 1998;17:2593\u2013600.","journal-title":"Oncogene"},{"key":"1724_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","volume":"4","author":"S Wang","year":"2003","unstructured":"Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, et al. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell. 2003;4:209\u201321.","journal-title":"Cancer Cell"},{"key":"1724_CR23","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1158\/0008-5472.CAN-09-2370","volume":"70","author":"MK Thomsen","year":"2010","unstructured":"Thomsen MK, Ambroisine L, Wynn S, Cheah KS, Foster CS, Fisher G, et al. SOX9 elevation in the prostate promotes proliferation and cooperates with PTEN loss to drive tumor formation. Cancer Res. 2010;70:979\u201387.","journal-title":"Cancer Res"},{"key":"1724_CR24","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/mt.2008.76","volume":"16","author":"C Zincarelli","year":"2008","unstructured":"Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 2008;16:1073\u201380.","journal-title":"Mol Ther"},{"key":"1724_CR25","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.ejca.2005.08.008","volume":"41","author":"K Milde-Langosch","year":"2005","unstructured":"Milde-Langosch K. The Fos family of transcription factors and their role in tumourigenesis. Eur J Cancer. 2005;41:2449\u201361.","journal-title":"Eur J Cancer"},{"key":"1724_CR26","doi-asserted-by":"crossref","unstructured":"Guo JC, Li J, Zhao YP, Zhou L, Cui QC, Zhou WX, et al. Expression of c-fos was associated with clinicopathologic characteristics and prognosis in pancreatic cancer. PLoS ONE. 2015;10:e0120332.","DOI":"10.1371\/journal.pone.0120332"},{"key":"1724_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/S1535-6108(03)00280-0","volume":"4","author":"A Fleischmann","year":"2003","unstructured":"Fleischmann A, Jochum W, Eferl R, Witowsky J, Wagner EF. Rhabdomyosarcoma development in mice lacking Trp53 and Fos: tumor suppression by the Fos protooncogene. Cancer Cell. 2003;4:477\u201382.","journal-title":"Cancer Cell"},{"key":"1724_CR28","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1046\/j.0022-3042.2002.00807.x","volume":"80","author":"A Wenzel","year":"2002","unstructured":"Wenzel A, Iseli HP, Fleischmann A, Hafezi F, Grimm C, Wagner EF, et al. Fra-1 substitutes for c-Fos in AP-1-mediated signal transduction in retinal apoptosis. J Neurochem. 2002;80:1089\u201394.","journal-title":"J Neurochem"},{"key":"1724_CR29","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/ncb2590","volume":"14","author":"L Min","year":"2012","unstructured":"Min L, Ji Y, Bakiri L, Qiu Z, Cen J, Chen X, et al. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat Cell Biol. 2012;14:1203\u201311.","journal-title":"Nat Cell Biol"},{"key":"1724_CR30","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1101\/gad.13.5.607","volume":"13","author":"M Schreiber","year":"1999","unstructured":"Schreiber M, Kolbus A, Piu F, Szabowski A, Mohle-Steinlein U, Tian J, et al. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev. 1999;13:607\u201319.","journal-title":"Genes Dev"},{"key":"1724_CR31","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1073\/pnas.0304146101","volume":"101","author":"J Lapointe","year":"2004","unstructured":"Lapointe J, Li C, Higgins JP, van de Rijn M, Bair E, Montgomery K, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci USA. 2004;101:811\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1724_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-1012-2","volume":"17","author":"M Haeussler","year":"2016","unstructured":"Haeussler M, Schonig K, Eckert H, Eschstruth A, Mianne J, Renaud JB, et al. Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR. Genome Biol. 2016;17:148.","journal-title":"Genome Biol"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41388-021-01724-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-021-01724-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41388-021-01724-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:22:04Z","timestamp":1684617724000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-021-01724-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,5]]},"references-count":32,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2021,4,1]]}},"alternative-id":["1724"],"URL":"https:\/\/doi.org\/10.1038\/s41388-021-01724-6","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,5]]},"assertion":[{"value":"10 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}